#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5116236	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as Akt degradation at 250 nM after 24 hrs by immunoblot analysis relative to control	Homo sapiens	2	ALA5113422	cell-based format	Scientific Literature
2.	ALA5116238	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as Akt degradation after 24 hrs by immunoblot analysis relative to control	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
3.	ALA5116239	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as Akt degradation at 250 nM after 2 hrs by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
4.	ALA5116240	B	Protac activity at CRBN/Akt1 in human Jeko-1 cells assessed as Akt1 degradation at 500 nM after 12 hrs by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
5.	ALA5116241	B	Protac activity at CRBN/Akt2 in human Jeko-1 cells assessed as Akt2 degradation at 500 nM after 12 hrs by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
6.	ALA5116242	B	Protac activity at CRBN/IKZF3 in human Jeko-1 cells assessed as IKZF3 degradation at 500 nM after 12 hrs by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
7.	ALA5116243	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as Akt degradation at 250 nM cotreated with proteasome inhibitor Bortezomib by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
8.	ALA5116244	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as Akt degradation at 250 nM cotreated with NEDD activating enzyme MLN4924 by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
9.	ALA5116245	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as decrease in phosphorylated GSK3beta level after 24 hrs by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
10.	ALA5116246	F	Antiproliferative activity against human Jeko-1 cells assessed as cell viability measured after 7 days by CCK-8 assay	Homo sapiens	5	ALA5113422	cell-based format	Scientific Literature
11.	ALA5116247	F	Antiproliferative activity against human Jeko-1 cells expressing CRBN-knockout assessed as cell viability measured after 7 days by CCK-8 assay	Homo sapiens	5	ALA5113422	cell-based format	Scientific Literature
12.	ALA5116248	F	Antiproliferative activity against human Mino cells assessed as cell viability measured after 7 days by CCK-8 assay	Homo sapiens	5	ALA5113422	cell-based format	Scientific Literature
13.	ALA5116249	F	Antiproliferative activity against human MM1.S cells assessed as cell viability measured after 3 days by CCK-8 assay	Homo sapiens	5	ALA5113422	cell-based format	Scientific Literature
14.	ALA5116250	F	Antiproliferative activity against human MM1.S cells assessed as cell viability measured after 7 days by CCK-8 assay	Homo sapiens	5	ALA5113422	cell-based format	Scientific Literature
15.	ALA5116251	F	Antiproliferative activity against human Jeko-1 cells assessed as cell viability measured after 3 days cotreated with Ibrutinib by CCK-8 assay	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature
16.	ALA5116252	B	Protac activity at CRBN/Akt in human Jeko-1 cells assessed as decrease in Myc level after 24 hrs cotreated with Ibrutinib by immunoblot analysis	Homo sapiens	1	ALA5113422	cell-based format	Scientific Literature